Takayuki Ohkuri

3.0k total citations
56 papers, 2.0k citations indexed

About

Takayuki Ohkuri is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Takayuki Ohkuri has authored 56 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Immunology, 25 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Takayuki Ohkuri's work include Immunotherapy and Immune Responses (33 papers), Immune Cell Function and Interaction (22 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Takayuki Ohkuri is often cited by papers focused on Immunotherapy and Immune Responses (33 papers), Immune Cell Function and Interaction (22 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Takayuki Ohkuri collaborates with scholars based in Japan, United States and Slovakia. Takayuki Ohkuri's co-authors include Akemi Kosaka, Takashi Nishimura, Hidemitsu Kitamura, Daiko Wakita, Kenji Chamoto, Hideho Okada, Hiroya Kobayashi, Toshihiro Nagato, Yuji Togashi and Yasuaki Harabuchi and has published in prestigious journals such as The Journal of Experimental Medicine, Cancer Research and Scientific Reports.

In The Last Decade

Takayuki Ohkuri

54 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Takayuki Ohkuri Japan	22	1.5k	976	583	204	141	56	2.0k
Sasikanth Manne United States	22	2.2k 1.5×	1.8k 1.8×	952 1.6×	87 0.4×	132 0.9×	32	3.4k
Katia Beider Israel	26	1.1k 0.7×	1.2k 1.2×	667 1.1×	88 0.4×	46 0.3×	62	2.2k
Tobias A.W. Holderried Germany	19	1.2k 0.8×	549 0.6×	629 1.1×	195 1.0×	63 0.4×	58	1.9k
Anupam M. Desai United States	7	870 0.6×	1.3k 1.3×	357 0.6×	107 0.5×	52 0.4×	11	1.9k
Sigrid Dubois United States	22	2.4k 1.6×	1.1k 1.2×	350 0.6×	221 1.1×	44 0.3×	37	2.9k
M. Ángela Aznar Spain	18	1.5k 1.1×	1.5k 1.5×	715 1.2×	97 0.5×	56 0.4×	23	2.5k
Marshall D. Behrens United States	21	1.0k 0.7×	1.0k 1.1×	646 1.1×	85 0.4×	54 0.4×	33	2.0k
Helena Escuin-Ordinas United States	13	1.0k 0.7×	1.4k 1.4×	644 1.1×	98 0.5×	43 0.3×	19	2.1k
Michal Abraham Israel	26	975 0.7×	724 0.7×	431 0.7×	181 0.9×	43 0.3×	46	1.8k
Nikita Kolhatkar United States	13	1.2k 0.8×	682 0.7×	433 0.7×	49 0.2×	84 0.6×	18	1.8k

Countries citing papers authored by Takayuki Ohkuri

Since Specialization

Citations

This map shows the geographic impact of Takayuki Ohkuri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takayuki Ohkuri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takayuki Ohkuri more than expected).

Fields of papers citing papers by Takayuki Ohkuri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takayuki Ohkuri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takayuki Ohkuri. The network helps show where Takayuki Ohkuri may publish in the future.

Co-authorship network of co-authors of Takayuki Ohkuri

This figure shows the co-authorship network connecting the top 25 collaborators of Takayuki Ohkuri. A scholar is included among the top collaborators of Takayuki Ohkuri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takayuki Ohkuri. Takayuki Ohkuri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kosaka, Akemi, Shunsuke Yasuda, Takahiro Inoue, et al.. (2025). Synergistic activation of STING and CD40 in the tumor microenvironment enhances CD8+ T-cell-dependent antitumor immunity. Biochemical and Biophysical Research Communications. 792. 152995–152995.

Inoue, Takahiro, Kenzo Ohara, Akemi Kosaka, et al.. (2025). Differences in PD‐L1, PD‐L2, and EGFR Expression Between Naive and Recurrent Tumors in Patients With Head and Neck Squamous Cell Carcinoma: A Retrospective Study. Head & Neck. 47(8). 2260–2269. 1 indexed citations

Nagato, Toshihiro, Miki Takahara, Takayuki Ohkuri, et al.. (2024). Soluble CD27 as a predictive biomarker for intra‐tumoral CD70/CD27 interaction in nasopharyngeal carcinoma. Cancer Science. 115(4). 1073–1084. 4 indexed citations

Kumai, Takumi, Toshihiro Nagato, Takayuki Ohkuri, et al.. (2024). Immunotherapy targeting tumor‐associated antigen in a mouse model of head and neck cancer. Head & Neck. 46(8). 2056–2067. 2 indexed citations

Kosaka, Akemi, Takayuki Ohkuri, Yoshihiko Hirohashi, et al.. (2023). SARS-CoV-2 spike protein-derived immunogenic peptides that are promiscuously presented by several HLA-class II molecules and their potential for inducing acquired immunity. Heliyon. 9(9). e20192–e20192. 1 indexed citations

Kosaka, Akemi, Kei Ishibashi, Shunsuke Yasuda, et al.. (2022). A tumor metastasis‐associated molecule TWIST1 is a favorable target for cancer immunotherapy due to its immunogenicity. Cancer Science. 113(8). 2526–2535. 8 indexed citations

Kumai, Takumi, Toshihiro Nagato, Takayuki Ohkuri, et al.. (2022). Mitogen‐activated protein kinase inhibition augments the T cell response against HOXB7‐expressing tumor through human leukocyte antigen upregulation. Cancer Science. 114(2). 399–409. 4 indexed citations

Kumai, Takumi, Toshihiro Nagato, Takayuki Ohkuri, et al.. (2022). Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma. OncoImmunology. 11(1). 2021619–2021619. 23 indexed citations

Kosaka, Akemi, Kei Ishibashi, Toshihiro Nagato, et al.. (2021). CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes. The Journal of Experimental Medicine. 218(11). 44 indexed citations

10.

Kumai, Takumi, Toshihiro Nagato, Takayuki Ohkuri, et al.. (2021). Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machinery. Cancer Immunology Immunotherapy. 70(12). 3421–3434. 11 indexed citations

11.

Ohara, Kenzo, Takumi Kumai, Takayuki Ohkuri, et al.. (2020). Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancer. Cancer Immunology Immunotherapy. 69(6). 989–999. 19 indexed citations

12.

Ohkuri, Takayuki, Arundhati Ghosh, Akemi Kosaka, et al.. (2014). STING Contributes to Antiglioma Immunity via Triggering Type I IFN Signals in the Tumor Microenvironment. Cancer Immunology Research. 2(12). 1199–1208. 196 indexed citations

13.

Ohkuri, Takayuki, Arundhati Ghosh, Akemi Kosaka, et al.. (2014). STING contributes to anti-glioma immunity via triggering type-I IFN signals in the tumor microenvironment. Journal for ImmunoTherapy of Cancer. 2(Suppl 3). P228–P228. 6 indexed citations

14.

Kosaka, Akemi, Takayuki Ohkuri, & Hideho Okada. (2014). Combination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cells. Cancer Immunology Immunotherapy. 63(8). 847–857. 82 indexed citations

15.

Takahashi, Norihiko, Takayuki Ohkuri, Shigenori Homma, et al.. (2012). First clinical trial of cancer vaccine therapy with artificially synthesized helper/ killer‐hybrid epitope long peptide of MAGE‐A4 cancer antigen. Cancer Science. 103(1). 150–153. 54 indexed citations

16.

Takeshima, Tsuguhide, Kenji Chamoto, Daiko Wakita, et al.. (2010). Local Radiation Therapy Inhibits Tumor Growth through the Generation of Tumor-Specific CTL: Its Potentiation by Combination with Th1 Cell Therapy. Cancer Research. 70(7). 2697–2706. 201 indexed citations

17.

Wakita, Daiko, Takayuki Ohkuri, Kenji Chamoto, et al.. (2010). 1α,25-Dihydroxyvitamin D3 and all-trans retinoic acid synergistically inhibit the differentiation and expansion of Th17 cells. Immunology Letters. 134(1). 7–16. 88 indexed citations

18.

Ashino, Shigeru, Daiko Wakita, Yoichiro Iwakura, et al.. (2010). A Th17-polarized cell population that has infiltrated the lung requires cells that convert to IFN-γ production in order to induce airway hyperresponsiveness. International Immunology. 22(6). 503–513. 18 indexed citations

19.

Ohkuri, Takayuki, Masayoshi Satō, Hiroyuki Abé, et al.. (2007). Identification of a novel NY‐ESO‐1 promiscuous helper epitope presented by multiple MHC class II molecules found frequently in the Japanese population. Cancer Science. 98(7). 1092–1098. 9 indexed citations

20.

Sasaki, Takeshi, Hiroaki Ikeda, Masayoshi Satō, et al.. (2006). Antitumor activity of chimeric immunoreceptor gene‐modified Tc1 and Th1 cells against autologous carcinoembryonic antigen‐expressing colon cancer cells. Cancer Science. 97(9). 920–927. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact